These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35056943)

  • 1. Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure.
    Wills KH; Behan SJ; Nance MJ; Dawson JL; Polasek TM; Hopkins AM; van Dyk M; Rowland A
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056943
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.
    Polasek TM; Tucker GT; Sorich MJ; Wiese MD; Mohan T; Rostami-Hodjegan A; Korprasertthaworn P; Perera V; Rowland A
    Br J Clin Pharmacol; 2018 Mar; 84(3):462-476. PubMed ID: 29194718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia.
    Lee J; Kim MG; Jeong HC; Shin KH
    Transl Clin Pharmacol; 2021 Mar; 29(1):33-44. PubMed ID: 33854999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics of Clozapine: A Systematic Review.
    Albitar O; Harun SN; Zainal H; Ibrahim B; Sheikh Ghadzi SM
    Biomed Res Int; 2020; 2020():9872936. PubMed ID: 31998804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
    Suttels V; André P; Thoma Y; Veuve F; Decosterd L; Guery B; Buclin T
    JAC Antimicrob Resist; 2022 Apr; 4(2):dlac043. PubMed ID: 35465238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring.
    Bolcato L; Thiebaut-Bertrand A; Stanke-Labesque F; Gautier-Veyret E
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs.
    Janssen JM; Dorlo TPC; Beijnen JH; Huitema ADR
    Ther Drug Monit; 2020 Aug; 42(4):532-539. PubMed ID: 32384536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design.
    Santacana E; Rodríguez-Alonso L; Padullés A; Guardiola J; Bas J; Rodríguez-Moranta F; Serra K; Morandeira F; Colom H; Padullés N
    Ther Drug Monit; 2020 Feb; 42(1):102-110. PubMed ID: 31283556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model.
    van den Born DA; Märtson AG; Veringa A; Punt NC; van der Werf TS; Alffenaar JC; Sturkenboom MGG; Touw DJ
    Int J Antimicrob Agents; 2023 Apr; 61(4):106750. PubMed ID: 36758777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.
    Ng W; Uchida H; Ismail Z; Mamo DC; Rajji TK; Remington G; Sproule B; Pollock BG; Mulsant BH; Bies RR
    Ther Drug Monit; 2009 Jun; 31(3):360-6. PubMed ID: 19349931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia.
    Li A; Ji S; Yue W; Yan H; Dong F; Ruan C; Li W; Lu W; Zhang D; Wang C
    BMJ Open; 2018 Aug; 8(8):e020070. PubMed ID: 30121590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding variability in the pharmacokinetics of atypical antipsychotics - focus on clozapine, olanzapine and aripiprazole population models.
    Jovanović M; Vučićević K; Miljković B
    Drug Metab Rev; 2020 Feb; 52(1):1-18. PubMed ID: 32008418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed dosing of kukoamine B in sepsis patients: Results from population pharmacokinetic modelling and simulation.
    Wang H; Wang T; Hu X; Deng C; Jiang J; Qin H; Dong K; Chen S; Jin C; Zhao Q; Du B; Hu P
    Br J Clin Pharmacol; 2022 Sep; 88(9):4111-4120. PubMed ID: 35373389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
    Smith RL; O'Connell K; Athanasiu L; Djurovic S; Kringen MK; Andreassen OA; Molden E
    Transl Psychiatry; 2020 Jun; 10(1):198. PubMed ID: 32555152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
    Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
    Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
    Arab-Alameddine M; Lubomirov R; Fayet-Mello A; Aouri M; Rotger M; Buclin T; Widmer N; Gatri M; Ledergerber B; Rentsch K; Cavassini M; Panchaud A; Guidi M; Telenti A; Décosterd LA; Csajka C;
    J Antimicrob Chemother; 2014 Sep; 69(9):2489-98. PubMed ID: 24821595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.